Bladder-sparing treatment for bladder cancer

Being diagnosed with bladder cancer can be a life-changing experience, and many patients understandably worry about the possibility of losing their bladder.

In this article, consultant urological surgeon Mr Rami Issa explains what bladder-sparing treatment involves, who may be suitable for it, and what patients can expect from this approach.

What is bladder-sparing treatment?

Bladder-sparing treatment refers to a combination of therapies that aim to treat bladder cancer while keeping the bladder intact. Traditionally, muscle-invasive bladder cancer has been treated with radical cystectomy, the complete surgical removal of the bladder. While this operation can be life-saving, it also has significant effects on lifestyle, urinary function, and overall quality of life.

Bladder-sparing treatment uses a carefully planned combination of surgery, chemotherapy, and radiotherapy to control or eradicate the cancer without removing the bladder in appropriately selected patients.

Who is suitable for bladder-sparing therapy?

Not every patient with bladder cancer will be a candidate for this approach. It is usually considered for individuals with muscle-invasive bladder cancer (where the tumour has grown into the bladder muscle) who meet certain criteria, such as:

• Having a single, small tumour that can be completely removed during initial surgery.
• No evidence of cancer spread outside the bladder.
• Good bladder function and general health to tolerate chemoradiotherapy.

Your urologist will assess your scans, biopsy results, and overall health before advising whether bladder preservation is a safe and effective option for you.

What does the treatment involve?

The bladder-sparing approach typically involves three main stages:

1. Transurethral resection of the bladder tumour (TURBT)

This minimally invasive procedure removes visible tumour tissue using instruments passed through the urethra. It provides both diagnosis and initial treatment, helping determine if further bladder-sparing therapy is suitable.

2. Chemoradiotherapy

Following TURBT, a combination of chemotherapy and radiotherapy is used to destroy any remaining cancer cells. Chemotherapy enhances the effectiveness of radiotherapy, reducing the risk of recurrence. Treatment is delivered over several weeks and usually does not require an overnight hospital stay.

3. Close monitoring

After treatment, regular follow-up is essential. This includes cystoscopy (inspection of the bladder with a camera) and imaging scans to detect any recurrence early. If the cancer returns or does not respond fully to therapy, radical cystectomy may still be recommended as a secondary treatment.

Advantages and considerations

The main advantage of bladder-sparing treatment is the preservation of the bladder and, in many cases, maintenance of normal urinary function. Patients may also experience a better quality of life compared with those undergoing bladder removal and reconstruction.

However, this approach requires strict follow-up and a commitment to ongoing monitoring. Side effects from radiotherapy and chemotherapy can include bladder irritation, fatigue, or bowel changes, though these are often temporary and manageable.

If you have been diagnosed with bladder cancer, consult with Mr Issa via his Top Doctors profile to determine whether bladder-sparing therapy could be the right option for you.